Back

argenx SE

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

  • Registration date 22 aug 2018 - 08:00
  • Statutory name argenx SE
  • Title argenx announces that AbbVie has exercised its exclusive option to license ARGX-115, a novel immuno-oncology antibody

Related downloads

201808220000000006_argenx announces that AbbVie has exercised its exclusive option to license ARGX-115, a novel immuno-oncology antibody.pdf

Date last update: 21 November 2018

Share information

Share on: Share this